Dyne Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 16.69 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.12B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incor...